data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Nkarta
(NASDAQ:NKTX)
$13.18
0.86[6.98%]
At close: Jul 1
$13.18
00
After Hours: 4:30PM EDT
Day High/Low12.19 - 13.24
52 Week High/Low7.55 - 40.64
Open / Close12.54 / 13.18
Float / Outstanding42.5M / 48.4M
Vol / Avg.514.8K / 3.2M
Mkt Cap638M
P/E-
50d Avg. Price13.99
Div / Yield-
Payout Ratio-
EPS-0.79
Total Float42.5M

Nkarta (NASDAQ:NKTX), Quotes and News Summary

Nkarta (NASDAQ: NKTX)

Day High/Low12.19 - 13.24
52 Week High/Low7.55 - 40.64
Open / Close12.54 / 13.18
Float / Outstanding42.5M / 48.4M
Vol / Avg.514.8K / 3.2M
Mkt Cap638M
P/E-
50d Avg. Price13.99
Div / Yield-
Payout Ratio-
EPS-0.79
Total Float42.5M
Benzinga - Sponsored
Benzinga - May 12, 2022, 4:26PM
Benzinga - May 2, 2022, 9:00AM
Benzinga - Apr 26, 2022, 12:03PM
Benzinga - Apr 26, 2022, 4:23AM
Benzinga - Apr 26, 2022, 4:19AM
Benzinga - Apr 25, 2022, 4:01PM
Benzinga - Apr 25, 2022, 3:32PM
Benzinga - Apr 25, 2022, 2:14PM
Benzinga - Apr 25, 2022, 2:11PM
Benzinga - Apr 25, 2022, 12:01PM
Benzinga - Apr 25, 2022, 11:54AM
Benzinga - Apr 25, 2022, 10:46AM
Benzinga - Apr 25, 2022, 10:17AM
Benzinga - Apr 25, 2022, 8:58AM
Benzinga - Apr 25, 2022, 8:58AM
Benzinga - Apr 25, 2022, 8:23AM
Benzinga - Apr 25, 2022, 7:07AM
load more
Sector: Health Care.Industry: Biotechnology
Nkarta Inc is a biopharmaceutical company developing engineered natural killer (NK) cells to fight cancer. The company is focused on leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. It is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of tumor targets, and improve persistence for sustained activity in the body for the treatment of cancer. The company's operations are based in South San Francisco, California and it operates in one segment.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.790
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Nkarta Questions & Answers

Q
How do I buy Nkarta (NKTX) stock?
A

You can purchase shares of Nkarta (NASDAQ: NKTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Nkarta's (NKTX) competitors?
Q
What is the target price for Nkarta (NKTX) stock?
A

The latest price target for Nkarta (NASDAQ: NKTX) was reported by Raymond James on Tuesday, April 26, 2022. The analyst firm set a price target for 32.00 expecting NKTX to rise to within 12 months (a possible 142.79% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Nkarta (NKTX)?
A

The stock price for Nkarta (NASDAQ: NKTX) is $13.18 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Nkarta (NKTX) pay a dividend?
A

There are no upcoming dividends for Nkarta.

Q
When is Nkarta (NASDAQ:NKTX) reporting earnings?
A

Nkarta’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Nkarta (NKTX) going to split?
A

There is no upcoming split for Nkarta.

Q
What sector and industry does Nkarta (NKTX) operate in?
A

Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.